Federal Court Upholds CollaGenex Classification As Antibiotic
A federal court has upheld the U.S. Food and Drug Administration's classification of Periostat as an antibiotic drug, a decision that strips CollaGenex Pharmaceuticals Inc. of patent rights to the drug....To view the full article, register now.
Already a subscriber? Click here to view full article